Funding Rounds
Aurealis Pharma Series B (2019, $7M)
Aurealis PharmaBiopharmaceutical company focused on developing innovative therapies.
Summary
Stage: Series B
Raised Amount: $7.73M
Raised Date: 2019-01-01
Stage: Series B
Raised Amount: $7.73M
Raised Date: 2019-01-01